Estimation of proxicam β-cyclodextrine from marketed formulations by RP-HPLC

Gopal P. Jadhav; Tanya Roy; A. D. Deshpande; H. N. More

Estimation of proxicam β-cyclodextrine from marketed formulations by RP-HPLC

Gopal P. Jadhav, Tanya Roy, A. D. Deshpande, H. N. More

Research output: Contribution to journal › Article › peer-review

Abstract

Piroxicam β-cyclodextrine (PBCD) is a novel pharmaceutical form of piroxicam. The present paper describe simple, fast, accurate and sensitive RP-HPLC method for the assay of piroxicam β-cyclodextrine (PBCD) from its marketed tablet formulations on Elow finepak C₁₈-5 column using Acetonitrile : Water : Orthophosphoric acid (45 : 55 : 0.2 v/v) as mobile phase. The optimum chromatographic conditions for their determination are described. The detection was made at 356 nm and method has been evaluated statistically for its sensitivity, accuracy and precision.

Original language	English (US)
Pages (from-to)	506-508
Number of pages	3
Journal	Indian Drugs
Volume	36
Issue number	8
State	Published - 1999
Externally published	Yes

All Science Journal Classification (ASJC) codes

Pharmacology
Pharmaceutical Science
Drug Discovery

Cite this

@article{ae87c8b9759944d4b3f9204ed39cf8e1,

title = "Estimation of proxicam β-cyclodextrine from marketed formulations by RP-HPLC",

abstract = "Piroxicam β-cyclodextrine (PBCD) is a novel pharmaceutical form of piroxicam. The present paper describe simple, fast, accurate and sensitive RP-HPLC method for the assay of piroxicam β-cyclodextrine (PBCD) from its marketed tablet formulations on Elow finepak C18-5 column using Acetonitrile : Water : Orthophosphoric acid (45 : 55 : 0.2 v/v) as mobile phase. The optimum chromatographic conditions for their determination are described. The detection was made at 356 nm and method has been evaluated statistically for its sensitivity, accuracy and precision.",

author = "Jadhav, {Gopal P.} and Tanya Roy and Deshpande, {A. D.} and More, {H. N.}",

year = "1999",

language = "English (US)",

volume = "36",

pages = "506--508",

journal = "Indian Drugs",

issn = "0019-462X",

publisher = "Indian Drug Manufacturers' Association",

number = "8",

}

TY - JOUR

T1 - Estimation of proxicam β-cyclodextrine from marketed formulations by RP-HPLC

AU - Jadhav, Gopal P.

AU - Roy, Tanya

AU - Deshpande, A. D.

AU - More, H. N.

PY - 1999

Y1 - 1999

N2 - Piroxicam β-cyclodextrine (PBCD) is a novel pharmaceutical form of piroxicam. The present paper describe simple, fast, accurate and sensitive RP-HPLC method for the assay of piroxicam β-cyclodextrine (PBCD) from its marketed tablet formulations on Elow finepak C18-5 column using Acetonitrile : Water : Orthophosphoric acid (45 : 55 : 0.2 v/v) as mobile phase. The optimum chromatographic conditions for their determination are described. The detection was made at 356 nm and method has been evaluated statistically for its sensitivity, accuracy and precision.

AB - Piroxicam β-cyclodextrine (PBCD) is a novel pharmaceutical form of piroxicam. The present paper describe simple, fast, accurate and sensitive RP-HPLC method for the assay of piroxicam β-cyclodextrine (PBCD) from its marketed tablet formulations on Elow finepak C18-5 column using Acetonitrile : Water : Orthophosphoric acid (45 : 55 : 0.2 v/v) as mobile phase. The optimum chromatographic conditions for their determination are described. The detection was made at 356 nm and method has been evaluated statistically for its sensitivity, accuracy and precision.

UR - http://www.scopus.com/inward/record.url?scp=0032831876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032831876&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032831876

VL - 36

SP - 506

EP - 508

JO - Indian Drugs

JF - Indian Drugs

SN - 0019-462X

IS - 8

ER -

Estimation of proxicam β-cyclodextrine from marketed formulations by RP-HPLC

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this